CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 14 No. 2

The Costabile Article Reviewed

 

Cancer and Male Sexual Dysfunction

February 1, 2000

Dr. Costabile presents a thorough review of the biological causes of erectile dysfunction after cancer treatment and of our current range of medical treatments to restore erections. I believe, however, that despite the technical progress made in understanding and remediating erectile dysfunction during the last 20 years, the majority of men who develop such problems following cancer treatment still do not resume a satisfying sex life.

For example, after localized treatment for prostate cancer, whether with radical surgery or definitive radiotherapy, most men have impaired erections.[1-4] Several studies of this group of patients concur that 30% to 50% are distressed about their sexual dysfunction.[5-9] Yet, only a much smaller percentage of men ever seek medical help for their problems, and, of those who do, less than one-third find their treatments beneficial.[10] This quite modest satisfaction rate is very similar to that found in three long-term follow-up studies of diverse groups of men who sought treatment at impotence clinics for erection problems.[11-13]

Although the introduction of sildenafil(Drug information on sildenafil) (Viagra) may increase satisfaction rates somewhat, its strongest effects occur in men whose problems are based on anxiety alone, or those who have very mild organic impairment of the erectile reflex.[14] Erection problems following cancer treatment are typically more severe than those associated with anxiety or mild organic impairments, however.

Importance of Counseling

How can we close the gap between our technical knowledge on how to stiffen the phallus and our rather disappointing success rates in giving couples back a satisfying sex life? The key, I believe, lies in Dr. Costabile’s brief paragraph, headed “Counseling.”

Although urologists have staked their claim to the wonders and mysteries of the penis, mental health practitioners are often left with the considerable territory of the man attached to it and his partner. In fact, the urologic view of sexuality often reminds me of a line Mae West uttered in the movie, Myra Breckenridge (1970). Playing a casting director, she meets a new hopeful who states that he is 6 foot, 6 inches. West suggests that he just tell her about the 6 inches.

Barriers Preventing Men From Seeking Help

Emotional barriers prevent men from seeking help, and despite Bob Dole’s willingness to serve as the courageous, World War II–era poster boy for impotence, most men still feel stigmatized admitting that they have a sexual problem. And if they do win the struggle to broach the topic with their physician, they may, in many cases, be met with impatient dismissal. To be fair, time constraints play an important role in producing this attitude among physicians. In this era of managed care, the average visit with a family physician lasts only 10 minutes, including both the physical examination and all verbal communication.[15]

Just this week, my lunch companion at a medical conference, a young female family physician, told me that she and her office nurse had laughed when a pharmaceutical company representative had brought them sample questionnaires on erectile dysfunction, suggesting that they administer them to patients to increase the percentage of men who would discuss a sexual problem. “Who needs questionnaires? We already hear too much about those problems,” she said.

Counseling Must Include Adequate Patient Education

For those men who conquer the hurdles and actually reach the treatment stage, drop-out rates are extremely high. Although it seems simple to try a pill that may improve erections, sildenafil is often prescribed without instructions about its effective use.

I cannot count the number of times that I have heard of a man who took his little blue pill and then sat disconsolately, waiting for the automatic erection so that he could “surprise” his partner. But the erection never appeared. The need for mental and physical sexual stimulation, in addition to the medication, was never mentioned by his physician.

Following cancer treatment, a man and his wife should undergo joint counseling on how to comfortably resume sexual activity. They should be encouraged to attempt noncoital sex even if erections are insufficient for intercourse.[16]

Information about other aspects of sexuality besides erection should also be provided. For example, the majority of cancer treatments do not diminish a man’s capacity to feel sexual desire, enjoy erotic sensations on his genital area, or feel the pleasure of orgasm.[16] Nonetheless, these facts are rarely included in the doctor-patient discussion about erectile function. Having a hard erection is viewed as the sine qua non of sexual normalcy.

Including the Partner in Discussions

Leaving out the partner is another source of treatment failure. A partner’s acceptance of a man’s need to inject his penis with medication or to use a vacuum pump in order to have an erection depends on her understanding of the problem so that she does not misinterpret the absence of tumescence as an absence of attraction or desire. Even the use of sildenafil can be frightening if a woman fears that it will threaten her partner’s health.

The mental health professional who is best trained to provide this type of patient education and sexual counseling is often the least valued member of the treatment team. Third-party insurers typically exclude the treatment of sexual dysfunction from whatever paltry mental health benefits they still offer. Cancer survivors and their partners are often delighted to try herbal remedies, aromatherapy, acupuncture, or drumming, but are embarrassed and anxious about seeing a sex therapist.

We are a nation that believes in better life through chemistry. I believe, however, that all our talk about phosphodiesterase inhibitors and veno-occlusive dysfunction remains so much sound and fury when we forget that sex is a sharing of pleasure and intimacy between two people.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Raymond A. Costabile, MD


1. Litwin MS, Hays RD, Fink A, et al: Quality-of-life outcomes in men treated for early prostate cancer. JAMA 273:129-135,1995.

2. Talcott JA, Rieker P, Clark JA, et al: Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 16:275-283, 1998.

3. Fossa SD, Woehre H, Kurth KH, et al: Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol 31(suppl 3):3-8, 1997.

4. Helgason AR, Adolfsson J, Dickman P, et al: Factors associated with waning sexual function among elderly men and prostate cancer patients. J Urol 158:155-159, 1997.

5. Robinson JW, Dufour MS, Fung TS: Erectile functioning of men treated for prostate carcinoma. Cancer 79:538-544, 1997.

6. Karakiewicz PL, Aprikian AG, Bazinet M, et al: Patient attitudes regarding treatment-related erectile dysfunction at the time of early detection of prostate cancer. Urol 50:704-709, 1997.

7. Jonler M, Moon T, Brannan W, et al: The effect of age, ethnicity, and geographical location on impotence and quality of life. Br J Urol 75:651-655, 1995.

8. Fowler FJ Jr, Barry MJ, Lu-Yao G, et al: Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three Surveillance, Epidemiology, and End Result areas. J Clin Oncol 14:2258-2265, 1996.

9. Gaylis FD, Friedel WE, Armas OA: Radical retropubic prostatectomy outcomes at a community hospital. J Urol 159:167-171, 1998.

10. Schrader-Bogen CL, Kjellberg JL, McPherson CP, et al: Quality of life and treatment outcomes: Prostate carcinoma patients’ perspectives after prostatectomy or radiation therapy. Cancer 79:1977-1986, 1997.

11. Dewire DM, Todd E, Meyers P: Patient satisfaction with current impotence therapy. Wis Med J 94:542-544, 1995.

12. Jarow JP, Nana-Sinkam P, Sabbagh M, et al: Outcome analysis of goal-directed therapy for impotence. J Urol 155:1609-1612, 1996.

13. Hanash KA: Comparative results of goal-oriented therapy for erectile dysfunction. J Urol 157:2135-2138, 1997.

14. Goldstein I, Lue TF, Padma-Nathan H, et al: Oral sildenafil in the treatment of erectile dysfunction: The Sildenafil Study Group. N Engl J Med 338:1397-1404, 1998.

15. Stange KC, Zyzanski SJ, Jaen CF, et al: Illuminating the “black box”: A description of 4454 patient visits to 138 family physicians. J Fam Pract 46:377-389, 1998.

16. Schover LR: Sexuality and Fertility After Cancer, pp 42-51, 64-69, 106-111. New York, John Wiley & Sons, 1997.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Preventing Exposure to Hazardous Drugs
  • Conflicts of Interest in Medicine: What About Ties to Payers?
  • Planning Treatment for Women With Recurrent Epithelial Ovarian Cancer
  • Rising PSA Level in a 46-Year-Old Man
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy